Browsing publications by Professor Deborah Tweddle

Newcastle AuthorsTitleYear
Dr Lindi Chen
Dr Yan Zhao
Dr Gail Halliday
Philip Berry
Professor Herbie Newell
et al.
Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastoma2014
Nidal Boulos
Dr Michael Tilby
Professor Deborah Tweddle
Professor John Lunec
Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation2013
Dr Lindi Chen
Professor Deborah Tweddle
p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance2012
Nermine Basta
Dr Gail Halliday
Richard Feltbower
Dr Nicholas Bown
Professor Andrew Pearson
et al.
Factors associated with recurrence and length of survival following relapse in patients with neuroblastoma: a pilot study2012
Professor Deborah Tweddle
Professor John Lunec
MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-632012
Dr Jonathan Fisher
Professor Deborah Tweddle
Neonatal neuroblastoma2012
Professor Deborah Tweddle
The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform2012
Dr Nicholas Bown
Professor John Lunec
Professor Deborah Tweddle
A Multilocus Technique for Risk Evaluation of Patients with Neuroblastoma2011
Dr Jane Carr-Wilkinson
Bojidar Goranov
Dr Christopher Redfern
Laura Gamble
Professor John Lunec
et al.
Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression2011
Dr Simon Bomken
Dr Barry Davies
Mike Cole
Dr Katrina Wood
Maritsa McDermott
et al.
Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival2011
12345